HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koji Suzuki Selected Research

Canthaxanthin

1/2013Association of serum carotenoid levels with urinary albumin excretion in a general Japanese population: the Yakumo study.
1/2003Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koji Suzuki Research Topics

Disease

51Neoplasms (Cancer)
01/2022 - 01/2002
23Inflammation (Inflammations)
02/2022 - 05/2003
17Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2006
11Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 11/2004
10Hypertension (High Blood Pressure)
07/2022 - 04/2009
9Lung Neoplasms (Lung Cancer)
01/2022 - 12/2002
8Fibrosis (Cirrhosis)
04/2020 - 05/2003
7Obesity
07/2018 - 02/2002
7Infections
03/2018 - 01/2000
6Non-alcoholic Fatty Liver Disease
08/2022 - 09/2013
6Thrombosis (Thrombus)
01/2015 - 02/2002
6Urolithiasis
03/2014 - 12/2005
6Myocardial Infarction
01/2014 - 06/2004
6Asthma (Bronchial Asthma)
01/2011 - 03/2004
5Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2022 - 01/2008
5Neoplasm Metastasis (Metastasis)
06/2015 - 01/2004
5Prostatic Neoplasms (Prostate Cancer)
09/2014 - 01/2004
5Colonic Neoplasms (Colon Cancer)
01/2014 - 03/2004
5Lung Injury
01/2014 - 05/2004
4Diabetes Mellitus
08/2022 - 09/2002
4Insulin Resistance
01/2022 - 02/2002
4Sepsis (Septicemia)
11/2019 - 01/2003
4Osteoarthritis
06/2018 - 01/2004
4Arthritis (Polyarthritis)
01/2016 - 05/2004
4Carcinogenesis
09/2014 - 02/2007
4Urinary Calculi (Urinary Calculus)
03/2014 - 08/2004
4Renal Cell Carcinoma (Grawitz Tumor)
02/2011 - 02/2002
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2011 - 02/2003
4Reperfusion Injury
08/2010 - 02/2009
4Ischemia
08/2010 - 06/2003
3Necrosis
01/2022 - 02/2009
3Pain (Aches)
09/2020 - 01/2004
3Osteoporosis
01/2020 - 12/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2003
3Dyslipidemias (Dyslipidemia)
11/2019 - 01/2013
3Adenocarcinoma
03/2018 - 07/2004
3Rheumatoid Arthritis
03/2018 - 06/2009
3Parkinson Disease (Parkinson's Disease)
01/2016 - 01/2011
3Breast Neoplasms (Breast Cancer)
05/2015 - 09/2007
3T-Cell Leukemia (Leukemia, T Cell)
01/2012 - 01/2009

Drug/Important Bio-Agent (IBA)

23Carotenoids (Carotene)IBA
01/2022 - 01/2000
15Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2002
13Proteins (Proteins, Gene)FDA Link
03/2022 - 02/2004
11CytokinesIBA
01/2015 - 03/2004
10MicroRNAs (MicroRNA)IBA
07/2022 - 09/2013
10Protein CIBA
01/2015 - 05/2003
9C-Reactive ProteinIBA
02/2022 - 07/2003
9Tocopherols (Tocopherol)IBA
12/2011 - 07/2002
8AntioxidantsIBA
01/2013 - 07/2002
8Vitamin A (Retinol)FDA LinkGeneric
07/2010 - 07/2002
7ThrombomodulinIBA
01/2022 - 01/2003
7beta Carotene (Betacarotene)FDA Link
05/2017 - 07/2002
7LycopeneIBA
01/2013 - 07/2002
6ORALIT (ORS)IBA
07/2022 - 01/2003
6Calcium OxalateIBA
03/2014 - 02/2005
6Insulin-Like Growth Factor I (IGF-1)IBA
06/2010 - 12/2002
6Insulin-Like PeptidesIBA
06/2010 - 12/2002
6ThrombinFDA Link
05/2010 - 01/2004
6Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
04/2009 - 02/2002
5Indicators and Reagents (Reagents)IBA
03/2022 - 02/2002
5Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2008
5AnticoagulantsIBA
01/2022 - 05/2003
5Protein C InhibitorIBA
06/2015 - 06/2003
5CollagenIBA
01/2014 - 05/2004
5OvalbuminIBA
08/2013 - 03/2004
5Insulin-Like Growth Factor Binding Protein 3IBA
06/2010 - 12/2002
4LipopolysaccharidesIBA
02/2022 - 01/2003
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2002
4Messenger RNA (mRNA)IBA
01/2022 - 04/2003
4Thromboplastin (Tissue Factor)IBA
01/2022 - 02/2002
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 12/2009
4EnzymesIBA
01/2019 - 01/2004
4Carrier Proteins (Binding Protein)IBA
01/2016 - 01/2005
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2015 - 02/2004
4Fibrinogen (Factor I)FDA Link
01/2014 - 04/2006
4LuteinIBA
12/2011 - 07/2002
4ZeaxanthinsIBA
12/2011 - 07/2002
4Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2010 - 12/2002
4FibrinIBA
06/2009 - 01/2003
4Beta-CryptoxanthinIBA
02/2007 - 01/2003
3LipidsIBA
08/2022 - 10/2013
3Uric Acid (Urate)IBA
01/2022 - 10/2009
3InterleukinsIBA
01/2022 - 01/2012
3HDL CholesterolIBA
12/2021 - 01/2008
3Peptide Hydrolases (Proteases)FDA Link
06/2015 - 09/2007
3AntibodiesIBA
06/2015 - 01/2000
3ChemokinesIBA
01/2014 - 06/2009
3CalciumIBA
12/2012 - 04/2009
3Hyaluronic Acid (Hyaluronan)IBA
10/2012 - 01/2010
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2012 - 01/2009
3Inositol (Myoinositol)IBA
01/2012 - 01/2009
3Biological ProductsIBA
01/2011 - 05/2003

Therapy/Procedure

9Therapeutics
04/2014 - 02/2003
6Drug Therapy (Chemotherapy)
01/2017 - 01/2004
5Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022 - 01/2004
3Chemoprevention
05/2017 - 01/2011
3Hematopoietic Stem Cell Transplantation
10/2013 - 02/2012
3Transplantation
10/2013 - 03/2003
3Renal Dialysis (Hemodialysis)
02/2011 - 02/2002